Ann Raju Punnoose MD
Pediatric Heart Failure and Heart Transplantation
Medical Officer, Center for Drug Evaluation and Research at the Food and Drug Administration
Join to View Full Profile
10903 New Hampshire AvenueSilver Spring, MD 20993
Dr. Punnoose is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
McGaw Medical Center of Northwestern University/Ann & Robert H Lurie Children's Hospital of ChicagoFellowship, Senior Fellow, Pediatric Heart Failure & Transplant , 2015 - 2016
Children's National Hospital/George Washington UniversityFellowship, Pediatric Cardiology, 2012 - 2015
Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterResidency, Pediatrics, 2008 - 2011
Pennsylvania State University College of MedicineClass of 2008
Certifications & Licensure
DC State Medical License 2012 - 2026
WI State Medical License 2016 - 2021
IL State Medical License 2015 - 2017
NY State Medical License 2009 - 2012
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Cardiology
Publications & Presentations
PubMed
- 6 citationsModel-Informed Approach Supporting Approval of Nexviazyme (Avalglucosidase Alfa-ngpt) in Pediatric Patients with Late-Onset Pompe Disease.Ruo-Jing Li, Lian Ma, Katarzyna Drozda, Jie Wang, Ann R Punnoose
The AAPS Journal. 2023-01-18 - 4 citationsRegulatory news: Avalglucosidase alfa-ngpt (Nexviazyme) for late-onset Pompe disease-FDA approval summary.Ann R Punnoose, Linda J B Jeng, Janet W Maynard,
Journal of Inherited Metabolic Disease. 2022-11-01 - 7 citationsPathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial translation defect.Marisa W. Friederich, Gabrielle C. Geddes, Saskia B. Wortmann, Ann Punnoose, Eric P. Wartchow
Molecular Genetics and Metabolism. 2021-06-10
Press Mentions
'Impossible' FDA Adcomm Ends in Favor of Stealth’s Ultra-Rare Disease MedOctober 10th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
